Repetitive Transcranial Magnetic Stimulation (rTMS) Modulates Thyroid Hormones Level and Cognition in the Recovery Stage of Stroke Patients with Cognitive Dysfunction

23 October 2021: Clinical Research

Hong Li ^1AE* , Jiang Ma ^1AE** , Jun Zhang ^2C , Wan-Ying Shi ^3F , Hao-Nan Mei ^2B , Yan Xing ^1C

DOI: 10.12659/MSM.931914

Med Sci Monit 2021; 27:e931914

Table 4 Comparison of post-treatment change (post-test–pre-test) in cognitive function scores between the 2 groups.

Group	MoCA	Visuospatial function	Memory	Language	Attention	MBI
rTMS (n=33)	6.00 (5.00, 6.50)	1.00 (0.50, 2.00)	1.00 (1.00, 2.00)	0.00 (0.00, 1.00)	1.00 (1.00, 2.00)	14.00 (9.00, 20.50)
Sham (n=32)	2.00 (0.25, 3.00)	1.00 (0.00, 1.00)	1.00 (0.00, 1.00)	0.00 (0.00, 1.00)	1.00 (0.00, 1.00)	5.00 (−1.50, 11.25)
U	−4.581	−2.531	−3.648	−0.413	−2.918	−3.369
P		0.011		0.680		0.001
Data presented as median (P25, P75). rTMS – repetitive transcranial magnetic stimulation; MoCA – Montreal Cognitive Assessment scale; MBI – Modified Barthel Index.